Abstract
Canavan disease (CD) is a rare metabolic disorder caused by aspartoacylase (ASPA) deficiency. It leads to severe neurological degeneration with spongiform brain degeneration. Accumulation of N-acetylaspartate (NAA) in brain and urine is specific to the disease and guides diagnosis. Magnetic resonance imaging (MRI) usually shows diffuse white matter abnormalities with involvement of the basal ganglia. Mild forms of the disease with a more favorable clinical course and radiological involvement of the basal ganglia without white matter abnormalities have also been reported. Here we report an atypical case of a girl aged nine years with CD. The disease started at the classical age of five months. Classical elevation of NAA in brain and urine was present and genetic analysis identified mutations in the ASPA gene. However, clinical evolution was milder than typical CD, with partial motor impairment and relatively well-preserved cognitive skills. MRI was also atypical with low white matter involvement and unusual topography and evolution of abnormalities in the basal ganglia.
This is a preview of subscription content, log in via an institution to check access.
References
Baslow MH, Guilfoyle DN (2013) Canavan disease, a rare early-onset human spongiform leukodystrophy: insights into its genesis and possible clinical interventions. Biochimie 95:946–956
Elpeleg ON, Shaag A (1999) The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-Jewish patients. J Inherit Metab Dis 22:531–534
Francis JS, Markov V, Leone P (2014) Dietary triheptanoin rescues oligodendrocyte loss, dysmyelination and motor function in the nur7 mouse model of Canavan disease. J Inherit Metab Dis 37:369–381
Guo F, Bannerman P, Mills Ko E, et al. (2015) Ablating N-acetylaspartate prevents leukodystrophy in a Canavan disease model. Ann Neurol 77:884–888
Hershfield JR, Pattabiraman N, Madhavarao CN, Namboodiri MA (2007) Mutational analysis of aspartoacylase: implications for Canavan disease. Brain Res 1148:1–14
Hoshino H, Kubota M (2014) Canavan disease: clinical features and recent advances in research. Pediatr Int 56:477–483
Janson CG, Kolodny EH, Zeng BJ, et al. (2006) Mild-onset presentation of Canavan’s disease associated with novel G212A point mutation in aspartoacylase gene. Ann Neurol 59:428–431
Madhavarao CN, Arun P, Moffett JR, et al. (2005) Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan’s disease. Proc Natl Acad Sci U S A 102:5221–5226
Matalon R, Michals-Matalon K (1999) Canavan Disease. In: Pagon RA, Adam MP, Ardinger HH, et al. (eds) GeneReviews (internet), Seattle, pp. 1993–2015 (updated 2011)
Michals K, Matalon R (2011) Canavan disease. In: Raymond GV, Eichler F, Fatemi A, Naidu S, Leukodystrophies (eds) London, Mac Keith Press, 2:156–69
Michel SJ, Given CA (2006) Case 99: Canavan disease. Radiology 241:310–314
Nave KA, Trapp BD (2008) Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 31:535–561
Nguyen HV, Ishak GE (2015) Canavan disease - unusual imaging features in a child with mild clinical presentation. Pediatr Radiol 45:457–460
Toft PB, Geiss-Holtorff R, Rolland MO, et al. (1993) Magnetic resonance imaging in juvenile Canavan disease. Eur J Pediatr 152:750–753
Velinov M, Zellers N, Styles J, Wisniewski K (2008) Homozygosity for mutation G212A of the gene for aspartoacylase is associated with atypical form of Canavan’s disease. Clin Genet 73:288–289
Wittsack HJ, Kugel H, Roth B, Heindel W (1996) Quantitative measurements with localized 1 H MR spectroscopy in children with Canavan’s disease. J Magn Reson Imaging 6:889–893
Yalcinkaya C, Benbir G, Salomons GS et al (2005) Atypical MRI findings in Canavan disease: a patient with a mild course. Neuropediatrics 36:336–339.
Zafeiriou DI, Kleijer WJ, Maroupoulos G, et al. (1999) Protracted course of N-acetylaspartic aciduria in two non-Jewish siblings: identical clinical and magnetic resonance imaging findings. Brain Dev 21:205–208
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors declare that they have no conflict of interest.
Informed consent
All the procedures followed complied with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards”. Informed consent was obtained from the patient’s family before inclusion in the study.
Additional information
Take-home message
• Moderate and atypical phenotype is a possible presentation of Canavan disease.
• Cerebral MRI can show mainly abnormalities in the basal ganglia rather than white matter abnormalities. Those abnormalities change in the course of the disease.
Rights and permissions
About this article
Cite this article
Sarret, C., Boespflug-Tanguy, O. & Rodriguez, D. Atypical clinical and radiological course of a patient with Canavan disease. Metab Brain Dis 31, 475–479 (2016). https://doi.org/10.1007/s11011-015-9767-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-015-9767-9